In addition, our results revealed that silencing of c-Met substantially increased the protein expression of cleaved caspase-3 (c-caspase-3) and the activity of caspase-3 in osimertinib-resistant NSCLC cells (Figure 1, F–H). The gene discussed is MET; the disease is non-small cell lung carcinoma.